Stay updated on ELiSA Study: Lixivaptan in ADPKD Clinical Trial
Sign up to get notified when there's something new on the ELiSA Study: Lixivaptan in ADPKD Clinical Trial page.

Latest updates to the ELiSA Study: Lixivaptan in ADPKD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe revision label changed from v3.3.1 to v3.3.2, and no study data, statuses, or contact information appears altered; to avoid alerts from small changes, set an alert condition.SummaryDifference0.1%

- Check21 days agoChange DetectedThe Record History now includes a new revision entry (v3.3.1) and removes the previous entry (v3.2.0).SummaryDifference0.1%

- Check29 days agoChange DetectedThe government funding status notice banner was removed from the page, which does not affect study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check43 days agoChange DetectedNo substantive content changes are observed; the history page layout remains the same with only minor visual spacing differences. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference11%

- Check79 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.3%

Stay in the know with updates to ELiSA Study: Lixivaptan in ADPKD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ELiSA Study: Lixivaptan in ADPKD Clinical Trial page.